Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.24.1
Document and Entity Information - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Mar. 15, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-40890    
Entity Registrant Name AUGMEDIX, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 83-3299164    
Entity Address, Address Line One 111 Sutter Street    
Entity Address, Address Line Two Suite 1300    
Entity Address, City or Town San Francisco    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94104    
City Area Code (888)    
Local Phone Number 669-4885    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Trading Symbol AUGX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Entity Current Reporting Status Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 117,000
Entity Common Stock, Shares Outstanding (in shares)   48,739,739  
Documents Incorporated by Reference
Portions of the registrant’s Proxy Statement for the 2024 Annual Meeting of Stockholders are incorporated into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2023.
    
Entity Central Index Key 0001769804    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false